The rollout of antiretroviral therapy for HIV showed how global solidarity and smart policy can overcome barriers to new treatments, say Jirair Ratevosian and Jeffrey L Sturchio The arrival of ...

USA: Researchers have reported a potential risk of severe hypercalcemia when tirzepatide, a dual GIP and GLP-1 receptor ...

Findings from an international database seem encouraging but could be due to confounders or older GLP-1 receptor agonists.

In a rodent model of T2D, icovamenib in combination with low-dose semaglutide promoted enhanced glycemic control and body weight reduction with preservation of lean mass, outperforming the group given ...

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

"For them to work effectively, they need to be taken long term," cautioned epidemiologisy professor Reimar W. Thomsen.

Frontiers in Endocrinology is a contributor to the 2025 Top 10 Emerging Technologies Report launched at the WEF Annual ...

The long haul that Little has committed to could be quite long. Studies have shown that, upon stopping the drug, appetites ...

Diabetes can also weaken the brain’s protective barrier, letting harmful substances in. This leads to inflammation. Reduced ...

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

Researchers warn that widespread use of weight-loss drugs like Ozempic among women of reproductive age may pose hidden risks to pregnancy. Flinders University researchers caution that many women using ...

The National Institutes of Health’s flagship long COVID initiative, RECOVER—short for Researching COVID to Enhance Recovery—has after a year of deliberation selected several drug candidates to test as ...